P-105 PET/CT Has Prognostic Significance for CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma
Patrick Born, Maximilan Merz, Osama Sabri(Klinik und Poliklinik für Nuklearmedizin), Hans‐Jonas Meyer, Enrica Bach, Lars Kurch, Klaus H. Metzeler(University Hospital Leipzig), Carmen Herling(University Hospital Leipzig), Marco Herling(Unknown), Song Yau Wang(University Hospital Leipzig), Madlen Jentzsch, Sandra Hoffmann(Economic Research Service), Timm Denecke(Leipzig University), Uwe Platzbecker(National Center for Tumor Diseases), David Fandrei(Inserm), Luise Fischer(Deutsches Konsortium für Translationale Krebsforschung), Vladan Vucinik, Georg‐Nikolaus Franke(University Hospital Leipzig), Ronny Baber(Leipzig University), Andreas Boldt(Leipzig University), Simone Heyn(University Hospital Leipzig), Carmen Perez Fernandez
Cited by 0
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Percutaneous Coronary Angioplasty Compared With Exercise Training in Patients With Stable Coronary Artery Disease
|Circulation|2004|774
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
|Blood|2019|655
Annual Cost of Illness and Quality-Adjusted Life Year Losses in the United States Due to 14 Foodborne Pathogens
|Journal of Food Protection|2012|609